Dividend reinvestment boosts Haleon (OTC: HLNCF) insider holdings
Filing Impact
Filing Sentiment
Form Type
6-K
Rhea-AI Filing Summary
Haleon plc reported small share purchases by two senior insiders through dividend reinvestment. On 18 September 2025, Chief Marketing Officer Tamara Rogers acquired 5 Ordinary Shares of £0.01 each at a price of £3.441 per share on the London Stock Exchange.
On the same date, Independent Non-Executive Director Alan Stewart acquired 214 Ordinary Shares at a price of £3.424442 per share, also via dividend reinvestment on the London Stock Exchange. These transactions were disclosed as required for persons discharging managerial responsibilities.
Positive
- None.
Negative
- None.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of September
2025
Commission File Number: 001-41411
Haleon plc
(Translation
of registrant’s name into English)
Building 5, First Floor, The Heights,
Weybridge, Surrey, KT13 0NY
(Address
of principal executive offices)
Indicate
by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F:
|
|
Form
20-F ☒
|
Form
40-F ☐
|
|
EXHIBIT INDEX
|
Exhibit Number
|
Description
|
|
99.1
|
22
September 2025- “Director/PDMR
Shareholding”
|
99.1
Haleon plc: Director/PDMR
Shareholding
22 September 2025: Haleon
plc (the "Company" or "Haleon") (LSE/NYSE:HLN) today announces
notification and public disclosure in accordance with the
requirements of The UK Market Abuse Regulation of Transactions by
Persons Discharging Managerial Responsibilities
("PDMRs").
On 19 September 2025, the Company received notification of the
following transactions as detailed below.
|
1
|
Details of the person discharging managerial responsibilities /
person closely associated
|
|||||
|
a)
|
Name
|
Tamara
Rogers
|
||||
|
2
|
Reason for the notification
|
|||||
|
a)
|
Position/status
|
Chief
Marketing Officer - PDMR
|
||||
|
b)
|
Initial notification /Amendment
|
Initial
Notification
|
||||
|
3
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction
monitor
|
|||||
|
a)
|
Name
|
Haleon
plc
|
||||
|
b)
|
LEI
|
549300PSB3WWEODCUP19
|
||||
|
4
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transactions have been
conducted
|
|||||
|
a)
|
Description of the financial instrument, type of
instrument
Identification
code
|
Ordinary Shares of £0.01 each
GB00BMX86B70
|
||||
|
b)
|
Nature of the transaction
|
Acquisition of Ordinary Shares in respect of dividend
reinvestment.
|
||||
|
c)
|
Price(s) and volume(s)
|
|
|
|||
|
|
Price(s)
|
Volume(s)
|
|
|||
|
|
£3.441
|
5
|
||||
|
|
||||||
|
d)
|
Aggregated information
- Aggregated volume
- Price
|
N/A
|
||||
|
e)
|
Date of the transaction
|
18
September 2025
|
||||
|
f)
|
Place of the transaction
|
London
Stock Exchange (XLON)
|
||||
|
1
|
Details of the person discharging managerial responsibilities /
person closely associated
|
||||
|
a)
|
Name
|
Alan Stewart
|
|||
|
2
|
Reason for the notification
|
||||
|
a)
|
Position/status
|
Independent Non-Executive Director - PDMR
|
|||
|
b)
|
Initial notification /Amendment
|
Initial Notification
|
|||
|
3
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction
monitor
|
||||
|
a)
|
Name
|
Haleon plc
|
|||
|
b)
|
LEI
|
549300PSB3WWEODCUP19
|
|||
|
4
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transactions have been
conducted
|
||||
|
a)
|
Description of the financial instrument, type of
instrument
Identification code
|
Ordinary Shares of £0.01 each
GB00BMX86B70
|
|||
|
b)
|
Nature of the transaction
|
Acquisition of Ordinary Shares as a result of dividend
reinvestment
|
|||
|
c)
|
Price(s) and volume(s)
|
|
|
||
|
Price(s)
|
Volume(s)
|
|
|||
|
£3.424442
|
214
|
||||
|
|
|||||
|
d)
|
Aggregated information
- Aggregated volume
- Price
|
N/A
|
|||
|
e)
|
Date of the transaction
|
18 September 2025
|
|||
|
f)
|
Place of the transaction
|
London Stock Exchange (XLON)
|
|||
Amanda Mellor
Company Secretary
About Haleon
Haleon (LSE/NYSE: HLN) is a global leader in consumer health, with
a purpose to deliver better everyday health with humanity. Haleon's
product portfolio spans six major categories - Oral Health,
Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory
Health, Digestive Health and Therapeutic Skin Health and Other. Its
long-standing brands - such as Advil, Centrum, Otrivin,
Panadol, parodontax, Polident, Sensodyne,
Theraflu and Voltaren - are built on trusted science, innovation
and deep human understanding.
For more information, please visit www.haleon.com.
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
|
|
|
HALEON PLC
(Registrant)
|
|
|
Date: September 22,
2025
|
By:
|
/s/
Amanda Mellor
|
|
|
|
|
Name:
|
Amanda
Mellor
|
|
|
|
Title:
|
Company
Secretary
|
FAQ
What insider transactions did Haleon (HLNCF) report in this 6-K?
The report shows two insider acquisitions via dividend reinvestment on 18 September 2025, involving Ordinary Shares of Haleon plc.
Why were these Haleon (HLNCF) insider transactions disclosed?
They were disclosed as required under UK Market Abuse Regulation for transactions by Persons Discharging Managerial Responsibilities (PDMRs).
Who authorized the Haleon (HLNCF) 6-K filing?
The filing was signed on behalf of Haleon plc by Amanda Mellor, the Company Secretary.